The global Insulin Sensitizers Market is estimated to be valued at US$ 15.09 billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Insulin sensitizers are medications that help improve insulin sensitivity and reduce blood sugar levels in individuals suffering from insulin resistance. These drugs are primarily used in the treatment ... Read more

The Insulin Sensitizers Market is estimated to be valued at US$ 15.09 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
 

Market Overview:

Insulin sensitizers are used mostly to treat patients with type 2 diabetes where the body does not produce enough insulin or cells do not respond properly to ... Read more

Insulin sensitizers are oral hypoglycemic agents primarily used for the management of type 2 diabetes. They enhance the sensitivity of target cells to insulin and help maintain normal blood glucose levels. Some common insulin sensitizers include biguanides, thiazolidinediones and glitinides. The increasing prevalence of diabetes globally, largely driven by obesity and sedentary lifestyles, has boosted the demand for effective anti-diabetic drugs such as insulin sensitizers. It is ... Read more